W.R. Berkley Corp’s Pfizer PFE Stock Holding History

W.R. Berkley Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3M	Buy	+965,537	New	+$25.3M	1.07%	16
2016 Q1	–	Sell	-20,342	Closed	-$623K	–	78
2015 Q4	$623K	Buy	+20,342	New	+$640K	0.11%	58

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

W.R. Berkley Corp's PFE Position: Q2 2026 in Review

W.R. Berkley Corp opened a new position in Pfizer (PFE) in Q2 2026: 965,537 shares worth $23.3M. The stake represents 1.07% of the portfolio and ranks #16 among its holdings. This is a return to the name: W.R. Berkley Corp previously reported a position in PFE as recently as Q4 2015.

W.R. Berkley Corp first reported a position in PFE in Q4 2015 and has held it in 2 quarters since. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

W.R. Berkley Corp held 965,537 shares of Pfizer worth $23.3M as of Q2 2026.
Pfizer was a new W.R. Berkley Corp position in Q2 2026.
Pfizer made up 1.07% of W.R. Berkley Corp's portfolio in Q2 2026, its #16 holding.
W.R. Berkley Corp first reported a position in Pfizer in Q4 2015 and has held it in 2 quarters since.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on W.R. Berkley Corp's 13F filing for Q2 2026, filed 14 Aug 2026.